Curaleaf Condemns Aurora Cannabis for Rejecting Enhanced Bid Amid Board Dispute

Key Facts

1Curaleaf condemned Aurora Cannabis for rejecting its enhanced proposal, accusing the board of obstructing engagement and fair value.

Curaleaf Holdings condemned Aurora Cannabis for rejecting its enhanced acquisition proposal and accused the company's board of obstructing engagement. Benzinga reported that Curaleaf criticized the board's actions, claiming they prevent shareholders from achieving fair value.

ACB closed at $3.99 on October 16, 2026, while CURLF closed at $7.83 on the same date. This escalation follows Aurora Cannabis's continued rejection of proposals, leading Curaleaf to publicly pressure the board to engage in negotiations.